These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 33081658)

  • 41. (99m)Tc-DPD uptake reflects amyloid fibril composition in hereditary transthyretin amyloidosis.
    Pilebro B; Suhr OB; Näslund U; Westermark P; Lindqvist P; Sundström T
    Ups J Med Sci; 2016; 121(1):17-24. PubMed ID: 26849806
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Multimodal Imaging and Biomarkers in Cardiac Amyloidosis.
    Jung MH; Chang S; Han EJ; Youn JC
    Diagnostics (Basel); 2022 Mar; 12(3):. PubMed ID: 35328180
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cardiac amyloidosis imaging with amyloid positron emission tomography: A systematic review and meta-analysis.
    Kim YJ; Ha S; Kim YI
    J Nucl Cardiol; 2020 Feb; 27(1):123-132. PubMed ID: 30022405
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Monitoring cardiac amyloidosis with multimodality imaging.
    Starr N; Ioannou A; Martinez-Naharro A
    Rev Esp Cardiol (Engl Ed); 2024 Jan; 77(1):79-87. PubMed ID: 37696332
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Histological Typing in Patients With Cardiac Amyloidosis: JACC Review Topic of the Week.
    Gonzalez-Lopez E; McPhail ED; Salas-Anton C; Dominguez F; Gertz MA; Dispenzieri A; Dasari S; Milani P; Verga L; Grogan M; Palladini G; Garcia-Pavia P
    J Am Coll Cardiol; 2024 Mar; 83(11):1085-1099. PubMed ID: 38479957
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clinical profile and outcome of cardiac amyloidosis in a Spanish referral center.
    López-Sainz Á; Hernandez-Hernandez A; Gonzalez-Lopez E; Domínguez F; Restrepo-Cordoba MA; Cobo-Marcos M; Gómez-Bueno M; Hernandez-Perez FJ; Oteo JF; Mirelis JG; Cavero MA; Moñivas V; Mingo Santos S; de Haro-Del Moral FJ; Krsnik I; Salas C; Bornstein B; Briceño A; López JA; Vázquez J; Alonso-Pulpón L; Segovia J; Garcia-Pavia P
    Rev Esp Cardiol (Engl Ed); 2021 Feb; 74(2):149-158. PubMed ID: 32317158
    [TBL] [Abstract][Full Text] [Related]  

  • 47. 99mTc-DPD scintigraphy and SPECT/CT in patients with AL and ATTR type amyloidosis: Potential clinical implications.
    Lee J; Kim K; Choi JO; Kim SJ; Jeon ES; Choi JY
    Medicine (Baltimore); 2020 Jan; 99(4):e18905. PubMed ID: 31977903
    [TBL] [Abstract][Full Text] [Related]  

  • 48. United network for organ sharing outcomes after heart transplantation for al compared to ATTR cardiac amyloidosis.
    Griffin JM; Chiu L; Axsom KM; Bijou R; Clerkin KJ; Colombo P; Cuomo MO; De Los Santos J; Fried JA; Goldsmith J; Habal M; Haythe J; Helmke S; Horn EM; Latif F; Hi Lee S; Lin EF; Naka Y; Raikhelkar J; Restaino S; Sayer GT; Takayama H; Takeda K; Teruya S; Topkara V; Tsai EJ; Uriel N; Yuzefpolskaya M; Farr MA; Maurer MS
    Clin Transplant; 2020 Oct; 34(10):e14028. PubMed ID: 32623785
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Technetium pyrophosphate myocardial uptake and peripheral neuropathy in a rare variant of familial transthyretin (TTR) amyloidosis (Ser23Asn): a case report and literature review.
    Castaño A; Bokhari S; Brannagan TH; Wynn J; Maurer MS
    Amyloid; 2012 Mar; 19(1):41-6. PubMed ID: 22149423
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Potential Cardiac Amyloid PET/CT Imaging Targets for Differentiating Immunoglobulin Light Chain From Transthyretin Amyloidosis.
    Schindler TH; Sharma M; Valenta I; Imperiale A; Dilsizian V
    Curr Cardiol Rep; 2021 Jun; 23(7):76. PubMed ID: 34081210
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinical use of differential nuclear medicine modalities in patients with ATTR amyloidosis.
    Noordzij W; Glaudemans AW; Slart RH; Dierckx RA; Hazenberg BP
    Amyloid; 2012 Dec; 19(4):208-11. PubMed ID: 22913327
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Ten questions for the cardiologist about cardiac scintigraphy with bone tracers, amyloidosis and the heart].
    Porcari A; Rossi M; Dore F; Imazio M; Fontana M; Merlo M; Sinagra G
    G Ital Cardiol (Rome); 2022 Jun; 23(6):424-432. PubMed ID: 35674032
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Nuclear Imaging for the Diagnosis of Cardiac Amyloidosis in 2021.
    Li W; Uppal D; Wang YC; Xu X; Kokkinidis DG; Travin MI; Tauras JM
    Diagnostics (Basel); 2021 May; 11(6):. PubMed ID: 34070853
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cardiac microcalcifications in transthyretin (ATTR) amyloidosis.
    Thelander U; Westermark GT; Antoni G; Estrada S; Zancanaro A; Ihse E; Westermark P
    Int J Cardiol; 2022 Apr; 352():84-91. PubMed ID: 35077727
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Diagnosis of cardiac amyloidosis: a systematic review on the role of imaging and biomarkers.
    Kyriakou P; Mouselimis D; Tsarouchas A; Rigopoulos A; Bakogiannis C; Noutsias M; Vassilikos V
    BMC Cardiovasc Disord; 2018 Dec; 18(1):221. PubMed ID: 30509186
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Incidental Cardiac Uptake in Bone Scintigraphy Establishing a Diagnosis of Transthyretin Amyloid Cardiomyopathy: A Case Report].
    Chono T; Harada K; Asanuma O
    Nihon Hoshasen Gijutsu Gakkai Zasshi; 2023 Dec; 79(12):1370-1374. PubMed ID: 37766520
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Diagnostic Work-Up of Cardiac Amyloidosis Using Cardiovascular Imaging: Current Standards and Practical Algorithms.
    Korosoglou G; Giusca S; André F; Aus dem Siepen F; Nunninger P; Kristen AV; Frey N
    Vasc Health Risk Manag; 2021; 17():661-673. PubMed ID: 34720583
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Atrial fibrillation and subtype of atrial fibrillation in cardiac amyloidosis: clinical and echocardiographic features, impact on mortality.
    Sanchis K; Cariou E; Colombat M; Ribes D; Huart A; Cintas P; Fournier P; Rollin A; Carrié D; Galinier M; Maury P; Duparc A; Lairez O;
    Amyloid; 2019 Sep; 26(3):128-138. PubMed ID: 31172799
    [No Abstract]   [Full Text] [Related]  

  • 59. Low Sensitivity of Bone Scintigraphy in Detecting Phe64Leu Mutation-Related Transthyretin Cardiac Amyloidosis.
    Musumeci MB; Cappelli F; Russo D; Tini G; Canepa M; Milandri A; Bonfiglioli R; Di Bella G; My F; Luigetti M; Grandis M; Autore C; Perlini S; Perfetto F; Rapezzi C
    JACC Cardiovasc Imaging; 2020 Jun; 13(6):1314-1321. PubMed ID: 31864976
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Enhancing knowledge and awareness of transthyretin cardiac amyloidosis and shared decision-making among cardiology team members in Colorado, USA via an online educational initiative.
    Ismailov RM; Lerut J; Aceña Á; Khasanova ZD
    Hosp Pract (1995); 2022 Feb; 50(1):37-41. PubMed ID: 34879213
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.